Thermo Fisher Scientific’s Orbitrap GC-MS systems has new capabilities in high-resolution accurate mass for laboratories performing gas chromatography mass spectrometry.
Thermo Fisher Scientific’s Orbitrap GC-MS systems have new capabilities suited to provide highly sensitive, selective, and accurate compound identification of complex samples for both research and routine laboratories performing gas chromatography mass spectrometry (GC-MS).
The brand’s Q Exactive GC system provides data for compound discovery, identification, and quantitation for comprehensive analyses. The Exactive GC system delivers sensitive, routine-grade performance in both targeted and non-targeted screening protocols. Both systems provide improved resolving power, mass accuracy, linear dynamic range, and sensitivity of Orbitrap technology.
Features now include the addition of variable electron voltage (VeV) technology for electron ionization (EI), the brand’s high-resolution accurate mass (HRAM) metabolomics library, and the TraceFinder automated compound identification. The VeV technology enables low electron voltage settings to be used during EI protocols, promoting high mass signals and providing high sensitivity for compounds prone to extensive fragmentation, according to the company.
In the HRAM metabolomics library for EI, metabolite identification is streamlined. The library includes more than 800 metabolites, and the spectra is refined and curated with the elemental composition of each EI fragment verified. New TraceFinder software features a specialized spectral deconvolution library and automated compound identification to enable identification of challenging compounds. According to the company, with the addition of Kovats retention index to the scoring index of unknowns, user confidence in compound identification is improved, specifically in relation to isomeric compounds.
Source: Thermo Fisher Scientific
INTERPHEX 2025: Use of Walk-In Chambers for Bio/Pharma Development and Manufacturing
April 2nd 2025Sitting down with the PharmTech Group at INTERPHEX 2025, Christopher Murphy, director of Global Business Development and Service Customer Support at Environmental Specialties, discusses the design and critical role of walk-in chambers in the bio/pharmaceutical industry.
Transformations in Drug Development for Cell and Gene Therapies
March 28th 2025As a recognized leader in immunophenotyping for clinical trials, Kevin Lang from PPD discusses how spectral flow cytometry is transforming drug development, particularly in cell and gene therapies like CAR-T. He also dives into his award-winning research, including his 2024 WRIB Poster Award-winning work, and his insights from presenting at AAPS PharmSci360.
Advancing Clinical Trials with Spectral Flow Cytometry: A Conversation with Kevin Lang
March 28th 2025As a recognized leader in immunophenotyping for clinical trials, Kevin Lang from PPD discusses how spectral flow cytometry is transforming drug development, particularly in cell and gene therapies like CAR-T. He also dives into his award-winning research, including his 2024 WRIB Poster Award-winning work, and his insights from presenting at AAPS PharmSci360.
WMFTS’ BioPure to Showcase Single-Use Bioclamp with Refined Manufacturing at INTERPHEX 2025
April 1st 2025With advanced manufacturing, BioPure’s BioClamp connector is manufactured to be 13% lighter than the previous model, resulting in a 26% reduction in carbon dioxide emissions across the full lifecycle of the product.